{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:01:01Z","timestamp":1780279261589,"version":"3.54.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research Program of Department of Science and Technology of Heilongjiang Province","award":["2022ZXJ03C0"],"award-info":[{"award-number":["2022ZXJ03C0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04291-2","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T13:24:24Z","timestamp":1776518664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of CEP55 expression in non-small cell lung cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiaxu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"13","key":"4291_CR1","doi-asserted-by":"publisher","first-page":"17864","DOI":"10.18632\/aging.203289","volume":"13","author":"C Fang","year":"2021","unstructured":"Fang C, Liu F, Wang Y, Yuan S, Chen R, Qiu X, et al. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer. Aging. 2021;13(13):17864\u201379. https:\/\/doi.org\/10.18632\/aging.203289.","journal-title":"Aging"},{"key":"4291_CR2","doi-asserted-by":"publisher","unstructured":"Smolarz B, \u0141ukasiewicz H, Samulak D, Piekarska E, Ko\u0142aci\u0144ski R, Romanowicz H. Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature). Int J Mol Sci. 2025;26(5). https:\/\/doi.org\/10.3390\/ijms26052049.","DOI":"10.3390\/ijms26052049"},{"key":"4291_CR3","doi-asserted-by":"publisher","unstructured":"Vicidomini G. Current Challenges and Future Advances in Lung Cancer: Genetics, Instrumental Diagnosis and Treatment. Cancers (Basel). 2023;15(14). https:\/\/doi.org\/10.3390\/cancers15143710.","DOI":"10.3390\/cancers15143710"},{"key":"4291_CR4","doi-asserted-by":"publisher","unstructured":"Rina A, Maffeo D, Minnai F, Esposito M, Palmieri M, Serio VB, et al. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions. Cancers (Basel). 2024;16(16). https:\/\/doi.org\/10.3390\/cancers16162882.","DOI":"10.3390\/cancers16162882"},{"issue":"3","key":"4291_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1066896910361736","volume":"18","author":"G Pelosi","year":"2010","unstructured":"Pelosi G, Sonzogni A, Viale G. The classification of lung carcinoma: time to change the morphology-based approach? Int J Surg Pathol. 2010;18(3):161\u201372. https:\/\/doi.org\/10.1177\/1066896910361736.","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"4291_CR6","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1080\/10717544.2022.2120566","volume":"29","author":"N Wathoni","year":"2022","unstructured":"Wathoni N, Puluhulawa LE, Joni IM, Muchtaridi M, Mohammed AFA, Elamin KM, et al. Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer. Drug Deliv. 2022;29(1):2959\u201370. https:\/\/doi.org\/10.1080\/10717544.2022.2120566.","journal-title":"Drug Deliv"},{"issue":"16","key":"4291_CR7","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1158\/1078-0432.Ccr-22-3699","volume":"29","author":"LN Mathieu","year":"2023","unstructured":"Mathieu LN, Larkins E, Sinha AK, Mishra-Kalyani PS, Jafri S, Kalavar S, et al. FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC. Clin Cancer Res. 2023;29(16):2973\u20138. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-3699.","journal-title":"Clin Cancer Res"},{"key":"4291_CR8","doi-asserted-by":"publisher","first-page":"118237","DOI":"10.1016\/j.carbpol.2021.118237","volume":"268","author":"X Zhu","year":"2021","unstructured":"Zhu X, Yu Z, Feng L, Deng L, Fang Z, Liu Z, et al. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. Carbohydr Polym. 2021;268:118237. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118237.","journal-title":"Carbohydr Polym"},{"key":"4291_CR9","doi-asserted-by":"publisher","unstructured":"Feng Q, Xiao K. Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer. Pharmaceutics. 2022;14(12). https:\/\/doi.org\/10.3390\/pharmaceutics14122787.","DOI":"10.3390\/pharmaceutics14122787"},{"key":"4291_CR10","doi-asserted-by":"publisher","unstructured":"Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, et al. Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance. Cancers (Basel). 2018;10(7). https:\/\/doi.org\/10.3390\/cancers10070224.","DOI":"10.3390\/cancers10070224"},{"issue":"9","key":"4291_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/anie.201710398","volume":"57","author":"J Lategahn","year":"2018","unstructured":"Lategahn J, Keul M, Rauh D. Lessons To Be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer. Angew Chem Int Ed Engl. 2018;57(9):2307\u201313. https:\/\/doi.org\/10.1002\/anie.201710398.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"4291_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/coc.0000000000001138","volume":"48","author":"Z Qureshi","year":"2025","unstructured":"Qureshi Z, Altaf F, Jamil A, Siddique R. Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment. Am J Clin Oncol. 2025;48(1):44\u201354. https:\/\/doi.org\/10.1097\/coc.0000000000001138.","journal-title":"Am J Clin Oncol"},{"key":"4291_CR13","doi-asserted-by":"publisher","unstructured":"Cheng Z, Cui H, Wang Y, Yang J, Lin C, Shi X, et al. The advance of the third\u2013generation EGFR\u2013TKI in the treatment of non\u2013small cell lung cancer (Review). Oncol Rep. 2024;51(1). https:\/\/doi.org\/10.3892\/or.2023.8675.","DOI":"10.3892\/or.2023.8675"},{"issue":"4","key":"4291_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.devcel.2005.09.003","volume":"9","author":"M Fabbro","year":"2005","unstructured":"Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, et al. Cdk1\/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell. 2005;9(4):477\u201388. https:\/\/doi.org\/10.1016\/j.devcel.2005.09.003.","journal-title":"Dev Cell"},{"issue":"6","key":"4291_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/onc.2015.128","volume":"35","author":"J Jeffery","year":"2016","unstructured":"Jeffery J, Sinha D, Srihari S, Kalimutho M, Khanna KK. Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis. Oncogene. 2016;35(6):683\u201390. https:\/\/doi.org\/10.1038\/onc.2015.128.","journal-title":"Oncogene"},{"issue":"10","key":"4291_CR16","doi-asserted-by":"publisher","first-page":"e1009334","DOI":"10.1371\/journal.pgen.1009334","volume":"17","author":"B Rashidieh","year":"2021","unstructured":"Rashidieh B, Shohayeb B, Bain AL, Fortuna PRJ, Sinha D, Burgess A, et al. Cep55 regulation of PI3K\/Akt signaling is required for neocortical development and ciliogenesis. PLoS Genet. 2021;17(10):e1009334. https:\/\/doi.org\/10.1371\/journal.pgen.1009334.","journal-title":"PLoS Genet"},{"key":"4291_CR17","doi-asserted-by":"publisher","first-page":"1156177","DOI":"10.3389\/fonc.2023.1156177","volume":"13","author":"M Huang","year":"2023","unstructured":"Huang M, Zhong F, Chen M, Hong L, Chen W, Abudukeremu X, et al. CEP55 as a promising biomarker and therapeutic target on gallbladder cancer. Front Oncol. 2023;13:1156177. https:\/\/doi.org\/10.3389\/fonc.2023.1156177.","journal-title":"Front Oncol"},{"issue":"7","key":"4291_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11010-022-04607-w","volume":"478","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu Q, Li E, Shi T, Chen H. CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling. Mol Cell Biochem. 2023;478(7):1561\u201371. https:\/\/doi.org\/10.1007\/s11010-022-04607-w.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"4291_CR19","doi-asserted-by":"publisher","first-page":"Ed000142","DOI":"10.1002\/14651858.Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142. https:\/\/doi.org\/10.1002\/14651858.Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"key":"4291_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"1","key":"4291_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jrsm.1277","volume":"9","author":"E Mayo-Wilson","year":"2018","unstructured":"Mayo-Wilson E, Li T, Fusco N, Dickersin K. Practical guidance for using multiple data sources in systematic reviews and meta-analyses (with examples from the MUDS study). Res Synth Methods. 2018;9(1):2\u201312. https:\/\/doi.org\/10.1002\/jrsm.1277.","journal-title":"Res Synth Methods"},{"issue":"9","key":"4291_CR22","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1371\/journal.pmed.0050184","volume":"5","author":"A Ramasamy","year":"2008","unstructured":"Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 2008;5(9):e184. https:\/\/doi.org\/10.1371\/journal.pmed.0050184.","journal-title":"PLoS Med"},{"key":"4291_CR23","doi-asserted-by":"publisher","unstructured":"Li G-S, Zhang W, Huang W-Y, He R-Q, Huang Z-G, Gan X-Y, et al. CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers. BMC Pulm Med. 2023;23(1). https:\/\/doi.org\/10.1186\/s12890-023-02452-1.","DOI":"10.1186\/s12890-023-02452-1"},{"key":"4291_CR24","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.12659\/msm.907266","volume":"24","author":"XP Ma","year":"2018","unstructured":"Ma XP, Zhang W, Wu BQ, Qin J. Correlations Between mRNA Levels of Centrosomal Protein 55 (CEP55) and Clinical Features of Patients with Lung Cancer. Med Sci Monit. 2018;24:3093\u20137. https:\/\/doi.org\/10.12659\/msm.907266.","journal-title":"Med Sci Monit"},{"issue":"2","key":"4291_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ijc.32981","volume":"147","author":"F Fu","year":"2020","unstructured":"Fu F, Zhang Y, Gao Z, Zhao Y, Wen Z, Han H, et al. Development and validation of a five-gene model to predict postoperative brain metastasis in operable lung adenocarcinoma. Int J Cancer. 2020;147(2):584\u201392. https:\/\/doi.org\/10.1002\/ijc.32981.","journal-title":"Int J Cancer"},{"key":"4291_CR26","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.2147\/ott.S165750","volume":"11","author":"C Jiang","year":"2018","unstructured":"Jiang C, Zhang Y, Li Y, Lu J, Huang Q, Xu R, et al. High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer. Onco Targets Ther. 2018;11:4979\u201390. https:\/\/doi.org\/10.2147\/ott.S165750.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"4291_CR27","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.18632\/aging.205783","volume":"16","author":"W Yue","year":"2024","unstructured":"Yue W, Wang J, Lin B, Fu Y. Identifying lncRNAs and mRNAs related to survival of NSCLC based on bioinformatic analysis and machine learning. Aging. 2024;16(9):7799\u2013817. https:\/\/doi.org\/10.18632\/aging.205783.","journal-title":"Aging"},{"issue":"3","key":"4291_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/1759-7714.12330","volume":"7","author":"W Jiang","year":"2016","unstructured":"Jiang W, Wang Z, Chen G, Jia Y. Prognostic significance of centrosomal protein 55 in stage I pulmonary adenocarcinoma after radical resection. Thorac Cancer. 2016;7(3):316\u201322. https:\/\/doi.org\/10.1111\/1759-7714.12330.","journal-title":"Thorac Cancer"},{"issue":"6","key":"4291_CR29","doi-asserted-by":"publisher","first-page":"107016","DOI":"10.5306\/wjco.v16.i6.107016","volume":"16","author":"D Hu","year":"2025","unstructured":"Hu D, Yu J, Feng J, Liu P, Chen JM, Zhang HL. Comparison and trend analysis of cancer incidence in China and globally in 2022. World J Clin Oncol. 2025;16(6):107016. https:\/\/doi.org\/10.5306\/wjco.v16.i6.107016.","journal-title":"World J Clin Oncol"},{"issue":"1","key":"4291_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2015.09.009.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"4291_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/CJI.0b013e3181a1d109","volume":"32","author":"S Inoda","year":"2009","unstructured":"Inoda S, Hirohashi Y, Torigoe T, Nakatsugawa M, Kiriyama K, Nakazawa E, et al. Cep55\/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. J Immunother. 2009;32(5):474\u201385. https:\/\/doi.org\/10.1097\/CJI.0b013e3181a1d109.","journal-title":"J Immunother"},{"key":"4291_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1479-5876-9-153","volume":"9","author":"T Shiraishi","year":"2011","unstructured":"Shiraishi T, Terada N, Zeng Y, Suyama T, Luo J, Trock B, et al. Cancer\/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy. J Transl Med. 2011;9:153. https:\/\/doi.org\/10.1186\/1479-5876-9-153.","journal-title":"J Transl Med"},{"issue":"2","key":"4291_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ygeno.2005.11.006","volume":"87","author":"I Martinez-Garay","year":"2006","unstructured":"Martinez-Garay I, Rustom A, Gerdes HH, Kutsche K. The novel centrosomal associated protein CEP55 is present in the spindle midzone and the midbody. Genomics. 2006;87(2):243\u201353. https:\/\/doi.org\/10.1016\/j.ygeno.2005.11.006.","journal-title":"Genomics"},{"issue":"9","key":"4291_CR34","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1091\/mbc.e06-01-0015","volume":"17","author":"WM Zhao","year":"2006","unstructured":"Zhao WM, Seki A, Fang G. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Mol Biol Cell. 2006;17(9):3881\u201396. https:\/\/doi.org\/10.1091\/mbc.e06-01-0015.","journal-title":"Mol Biol Cell"},{"issue":"4","key":"4291_CR35","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1083\/jcb.201008108","volume":"191","author":"RN Bastos","year":"2010","unstructured":"Bastos RN, Barr FA. Plk1 negatively regulates Cep55 recruitment to the midbody to ensure orderly abscission. J Cell Biol. 2010;191(4):751\u201360. https:\/\/doi.org\/10.1083\/jcb.201008108.","journal-title":"J Cell Biol"},{"issue":"22","key":"4291_CR36","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.4161\/cc.8.22.10047","volume":"8","author":"A van der Horst","year":"2009","unstructured":"van der Horst A, Simmons J, Khanna KK. Cep55 stabilization is required for normal execution of cytokinesis. Cell Cycle. 2009;8(22):3742\u20139. https:\/\/doi.org\/10.4161\/cc.8.22.10047.","journal-title":"Cell Cycle"},{"issue":"10","key":"4291_CR37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ncb2332","volume":"13","author":"TC Kuo","year":"2011","unstructured":"Kuo TC, Chen CT, Baron D, Onder TT, Loewer S, Almeida S, et al. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol. 2011;13(10):1214\u201323. https:\/\/doi.org\/10.1038\/ncb2332.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4291_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.62347\/gqzh3508","volume":"14","author":"W Zhou","year":"2025","unstructured":"Zhou W, Liu X, Li Z, Jia B, Lei X, Sun K, et al. Epigenetic crosstalk between stem cells and tumors: mechanisms and emerging perspectives. Am J Stem Cells. 2025;14(3):98\u2013133. https:\/\/doi.org\/10.62347\/gqzh3508.","journal-title":"Am J Stem Cells"},{"issue":"29","key":"4291_CR39","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/sj.onc.1210207","volume":"26","author":"CH Chen","year":"2007","unstructured":"Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ, Tsou AP, et al. FLJ10540-elicited cell transformation is through the activation of PI3-kinase\/AKT pathway. Oncogene. 2007;26(29):4272\u201383. https:\/\/doi.org\/10.1038\/sj.onc.1210207.","journal-title":"Oncogene"},{"issue":"11","key":"4291_CR40","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.7150\/jca.15497","volume":"7","author":"G Wang","year":"2016","unstructured":"Wang G, Liu M, Wang H, Yu S, Jiang Z, Sun J, et al. Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt\/mTOR Signaling Pathway. J Cancer. 2016;7(11):1431\u201340. https:\/\/doi.org\/10.7150\/jca.15497.","journal-title":"J Cancer"},{"key":"4291_CR41","volume-title":"Research on the Role and Mechanism of CEP55 in the Occurrence and Development of Lung Adenocarcinoma","author":"TT Yang","year":"2024","unstructured":"Yang TT. Research on the Role and Mechanism of CEP55 in the Occurrence and Development of Lung Adenocarcinoma. Master: Henan University; 2024."},{"issue":"4","key":"4291_CR42","doi-asserted-by":"publisher","first-page":"e5052","DOI":"10.1371\/journal.pone.0005052","volume":"4","author":"CH Chen","year":"2009","unstructured":"Chen CH, Lai JM, Chou TY, Chen CY, Su LJ, Lee YC, et al. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K\/AKT pathway. PLoS ONE. 2009;4(4):e5052. https:\/\/doi.org\/10.1371\/journal.pone.0005052.","journal-title":"PLoS ONE"},{"issue":"4","key":"4291_CR43","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3892\/or.2016.5059","volume":"36","author":"L Liu","year":"2016","unstructured":"Liu L, Mei Q, Zhao J, Dai Y, Fu Q. Suppression of CEP55 reduces cell viability and induces apoptosis in human lung cancer. Oncol Rep. 2016;36(4):1939\u201345. https:\/\/doi.org\/10.3892\/or.2016.5059.","journal-title":"Oncol Rep"},{"issue":"2","key":"4291_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/10408363.2025.2555278","volume":"63","author":"D Sandai","year":"2026","unstructured":"Sandai D, Du Z, Zhang H, Sun Q. Regulatory mechanisms and emerging diagnostic and therapeutic opportunities of non-coding RNAs in tumorigenesis: a pan-cancer perspective. Crit Rev Clin Lab Sci. 2026;63(2):147\u2013203. https:\/\/doi.org\/10.1080\/10408363.2025.2555278.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"4","key":"4291_CR45","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s10528-023-10330-y","volume":"61","author":"L Fu","year":"2023","unstructured":"Fu L, Li Z, Wu Y, Zhu T, Ma Z, Dong L, et al. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7\/CEP55. Biochem Genet. 2023;61(4):1528\u201347. https:\/\/doi.org\/10.1007\/s10528-023-10330-y.","journal-title":"Biochem Genet"},{"issue":"8","key":"4291_CR46","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.62347\/gqva7530","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhao W, Zhao Z, Duan Z, Huang H, Ding C, et al. Hypoxia-anoikis-related genes in LUAD: machine learning and RNA sequencing analysis of immune infiltration and therapy response. Am J Cancer Res. 2025;15(8):3762\u201380. https:\/\/doi.org\/10.62347\/gqva7530.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4291_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yexmp.2010.10.001","volume":"90","author":"S Inoda","year":"2011","unstructured":"Inoda S, Morita R, Hirohashi Y, Torigoe T, Asanuma H, Nakazawa E, et al. The feasibility of Cep55\/c10orf3 derived peptide vaccine therapy for colorectal carcinoma. Exp Mol Pathol. 2011;90(1):55\u201360. https:\/\/doi.org\/10.1016\/j.yexmp.2010.10.001.","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"4291_CR48","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.ajpath.2011.01.004","volume":"178","author":"S Inoda","year":"2011","unstructured":"Inoda S, Hirohashi Y, Torigoe T, Morita R, Takahashi A, Asanuma H, et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am J Pathol. 2011;178(4):1805\u201313. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.004.","journal-title":"Am J Pathol"},{"issue":"6","key":"4291_CR49","first-page":"1456","volume":"20","author":"XY Gao","year":"2015","unstructured":"Gao XY, Wang XL. An adoptive T cell immunotherapy targeting cancer stem cells in a colon cancer model. J buon. 2015;20(6):1456\u201363.","journal-title":"J buon"},{"issue":"6","key":"4291_CR50","doi-asserted-by":"publisher","first-page":"106847","DOI":"10.5306\/wjco.v16.i6.106847","volume":"16","author":"D Wang","year":"2025","unstructured":"Wang D, Zhang HL, Zhang HL, Song ZJ, Doblin S, Lu P. Microbiota and cancer: Elucidating the role of Candida albicans in cancer progression. World J Clin Oncol. 2025;16(6):106847. https:\/\/doi.org\/10.5306\/wjco.v16.i6.106847.","journal-title":"World J Clin Oncol"},{"issue":"4","key":"4291_CR51","doi-asserted-by":"publisher","first-page":"104182","DOI":"10.5306\/wjco.v16.i4.104182","volume":"16","author":"HL Zhang","year":"2025","unstructured":"Zhang HL, Zhao R, Wang D, Mohd Sapudin SN, Yahaya BH, Harun MSR, et al. Candida albicans and colorectal cancer: A paradoxical role revealed through metabolite profiling and prognostic modeling. World J Clin Oncol. 2025;16(4):104182. https:\/\/doi.org\/10.5306\/wjco.v16.i4.104182.","journal-title":"World J Clin Oncol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04291-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:26:38Z","timestamp":1780277198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04291-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04291-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}